Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Background: Fatty liver disease is the most common finding in abdominal ultrasound examinations, wherein a relevant percentage
may develop liver cirrhosis. This study reveals the prevalence of hepatic fibrosis on patients who with fatty liver disease and takes
into account the association of both factors.
Aim & Method: All shear wave ultrasound results from February 1, 2016 to January 31, 2018 were reviewed. The total patients with
and without fatty liver disease and hepatic fibrosis were tabulated. Mean shear wave values were recorded and classified according
to the degree of fibrosis.
Result: Of the 208 patients having fatty liver disease, a total of 142 (68.3%) patients had evidence of fibrosis. Only 66 (31.7%)
patients had normal results. 126 (88.7%) of the patients with fibrosis had were classified mild, 12 (9.2%) of them were moderate
and 3 (2.1) were severe. 23 (16.2%) were within 20-39 years, 67 (47.2%) were between 40-59 years, 47 (33.10%) between 60-79
years and 5 (3.5%) were >80 years. 77 patients (54.2%) were male and 65 (45.8%) were female. Age and gender were tested for
correlation to hepatic fibrosis using a CI=95% which revealed a p-value of <0.98 for age and <0.93 for gender; both were not
significant. The prevalence of fibrosis in patients with hepatic steatosis was tested for significance with a CI=95% revealing a
p-value of <0.0001, which was significant. Association between steatosis and fibrosis was also tested using a CI=95% showing a
p-value of <0.0001, which was significant.
Conclusion: This study reveals that the prevalence of hepatic fibrosis on patients with fatty liver disease is statistically significant.
A significant association between fatty liver disease and hepatic fibrosis has been proven in this study. There is however, no gender
or age range predisposition for hepatic fibrosis.